We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Novel Detoxification Method Cures Opiate Addiction in 36 Hours

By HospiMedica International staff writers
Posted on 22 Oct 2009
A fast, painless, and effective method for treating opiate addiction can give positive results virtually overnight. More...


The Accelerated Neuroregulation (ANR) method, also known as the Waismann method after its inventor, Andre Waismann, M.D., of Barzilai Hospital (Ashkelon, Israel) reverses both the opiate dependency and its symptoms, and also works on heroine, methadone, subutex, and prescription opiates. The treatment begins during the evening hours, when the patient undergoes general anesthesia (GA) for a period of four hours, during which the opiates are ‘washed out' out of their brain. This is necessary due the intense pain felt during this initial withdrawal period. The patients are then given a cocktail of medically approved drugs to block the opiate receptors in the brain. The morning after, the patient begins post-ANR naltrexone treatment; a daily regimen of naltrexone is followed thereafter, which keeps the opioid receptors blocked, blocking out cravings and making them become irrelevant. Patients are encouraged to eat and drink, slowly returning to general physical activities, and are typically discharged the following noon; upon discharge, the withdrawal syndrome is over and patients are no longer dependent. The whole treatment from start to finish takes 36 hours. The length of the post-ANR Naltrexone treatment is established according to the specific needs of each patient, but is usually one year long.

"My goal is that any drug addict in the world will one day be able to turn up at their local general hospital and say, 'good evening, I am hooked on opiates,” said Dr. Waismann in a recent interview with The Independent newspaper. "They will then lie down on a treatment table and be cured quickly before going home healthy. It will be as simple as taking a trip to the dentist.”

Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol and opioid dependence. It is marketed in generic form as its hydrochloride salt, naltrexone hydrochloride. In rapid detoxification procedures, oral naltrexone daily for up to 12 months is used for opioid dependence management. There are a number of practitioners who will use a naltrexone implant placed in the lower abdomen, and more rarely, in the posterior to replace the oral naltrexone.

Related Links:

Barzilai Hospital


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.